Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for screening for compounds that inhibit neurodegeneration

A technology for neurodegeneration, candidate compounds, applied in biochemical equipment and methods, nervous system cells, assay/examination of microorganisms, etc.

Inactive Publication Date: 2011-07-13
GENENTECH INC
View PDF83 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] Although multiple TNF ligands and receptor family members have been identified with diverse biological activities and properties, few such ligands and receptors have been reported to be involved in neurologically relevant functions

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for screening for compounds that inhibit neurodegeneration
  • Method for screening for compounds that inhibit neurodegeneration
  • Method for screening for compounds that inhibit neurodegeneration

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0313] Example 1: DR6 expression in the embryonic and adult central nervous system

[0314] An RNA in situ screen for TNF receptor superfamily expression patterns in mouse embryonic tissues was performed. More specifically, in situ hybridization experiments were performed using the mRNA Locator Kit (Ambion, catalog number 1803) following the manufacturer's protocol. The following DR6 cDNA primary sequence was used to generate riboprobes for these experiments:

[0315] GAGCAGAAACGGCTCCTTTATTACCAAAGAAAAGAAGGACACAGTGTTGCGGCAGGTCCGCCTGGACCCCTGTGACTTGCAGCCCATCTTTGATGACATG CTGCATATCCTGAACCCCGAGGAGCTGCGGGTGATTGAAGAGATTCCCCAGGCTGAGGACAAACTGGACCGCCTCTTCGAGATCATTGGGGTCAAGAGCC AAGAAGCCAGCCAGACCCTCTTGGACTCTGTGTACAGTCATCTTCCTGACCTATTGTAGAACACAGGGGCACTGCATTCTGGGAATCAACCTACTGGCGG.(SEQ ID NO:3)

[0316] In vitro synthesis of riboprobes was performed using the Maxiscript kit (Ambion, catalog #1308) according to the manufacturer's protocol.

[0317] Such as Figure 2A In developing spinal co...

Embodiment 2

[0327] Example 2: Inhibition of DR6 expression by RNA interference prevents axonal degeneration of commissural neurons in explant cultures

[0328] Commissural neurons are a group of long-projecting spinal interneurons that arise in the dorsal spinal cord between developmental stages E9.5 and E11.5. The survival of commissural neurons is thought to be dependent on trophic support from one of their intermediate targets, the floor plate of the spinal cord. This dependence occurs during a period lasting several days, when their axons extend along the floor plate, after which they develop additional nutrient requirements. The dependence of neurons on trophic support incidentally derived from their intermediate axonal targets provides a mechanism for the rapid elimination of misprojecting neurons, which may help prevent the formation of aberrant neuronal circuits during the development of the nervous system (Wang et al., Nature , 401:765-769 (1999)).

[0329] To examine the fun...

Embodiment 3

[0342] Example 3: Inhibition of DR6 receptor signaling by anti-DR6 antibodies prevents axonal degeneration of commissural neurons in explant cultures

[0343] Dorsal spinal cord survival assays were performed using anti-DR6 antibodies (as described in Example 2 above). Microscopic observation (green fluorescence channel using GFP) was used to visualize commissural axons. Dorsal spinal cord survival assays were performed according to protocols known in the art (Kennedy et al. Cell 78: 425-435 (1994); Wang et al. Nature 401:765-769 (1999)), with the modifications outlined in Example 2 above. The GFP expression plasmid construct (subcloning the GFP cDNA into the pCAGGS vector backbone commercially available from BCCM / LMBP) was injected into the neural tube of E13 rat embryos. The GFP expression plasmid was then delivered to dorsal progenitor cells by electroporation. Anti-DR6 blocking antibody or control normal mouse IgG was added to commissural explants at 40 μg / ml 24 hou...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Methods for screening for compounds that inhibit neurodegeneration are presented. Shedding of APP can be a useful marker for neurodegeneration and compounds that inhibit shedding of APP are useful as inhibitors of neurodegeneration. Such compounds may be useful in treatment and / or prevention of various neurological diseases, disorders and neuronal damage and may enhance growth, regeneration or survival of mammalian neuronal cells or tissue.

Description

[0001] Cross References to Related Applications [0002] This application is a continuation-in-part of PCT Application No. PCT / US2007 / 88521, filed December 21, 2007, which requires U.S. Provisional Application No. 60 / , filed December 22, 2006 871,528 and 60 / 900,848 filed February 12, 2007 in interest. This application further claims the benefit of US Provisional Application No. 61 / 061,062, filed June 12, 2008. The contents of these applications are incorporated herein in their entirety by reference. field of invention [0003] The present invention generally relates to methods of screening for compounds that inhibit neuronal degeneration. More specifically, the method involves screening for compounds that inhibit APP shedding from neurons following a triggering event of neuronal degeneration. Background of the invention [0004] A variety of ligands and receptors belonging to the tumor necrosis factor (TNF) superfamily have been identified in the art. Among these ligands...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/50G01N33/15C12Q1/02
CPCG01N33/5058G01N33/6896C12Q1/02G01N33/15G01N33/50C12N5/0619
Inventor 安纳托利·尼古莱夫马克·特西尔-拉维格尼
Owner GENENTECH INC